SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras antibody candidate for menopausal hot flashes, and its Phase 1/2 data presentation at a menopause conference; traders are looking for added evidence on efficacy, durability and safety after encouraging Phase 2 topline results. Bulls see the data as a potential validation of the companys internal pipeline, while skeptics question whether the presentation adds enough beyond known results and warn that expectations and recent volatility may set up a sell-the-news reaction.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Renewed, unconfirmed takeover chatter around a possible offer from an unidentified West Coast technology company is dominating discussion, with traders speculating about buyers such as Meta while others caution that no bid has been confirmed. Upcoming earnings and concerns about transaction margins are also in focus, but the takeover speculation is driving much of the debate.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs choppy trading is drawing attention amid rotation between small caps and large-cap tech, with traders debating whether small caps relative resilience signals a broader recovery or a temporary bounce. Speculation about a U.S.Iran deal and swings in oil prices have added volatility, but the reported diplomatic progress is disputed and traders remain wary of weak breadth and technical resistance.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is drawing attention amid a steep, prolonged selloff, with traders citing weakness across Chinese EV stocks, concerns about demand, profitability and analyst downgrades. Bulls counter that delivery growth, European expansion and AI-chip and robotics initiatives could support the business, while frustrated holders question whether those developments can improve shareholder returns.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Phase 3 melanoma-vaccine results with Keytruda showed a 42% reduction in recurrence or death risk, but shares sold off as traders judged the outcome against high expectations after a major run-up. The community is split between viewing the data as strong validation of the cancer-vaccine platform and questioning whether the benefit, individualized manufacturing, and commercialization prospects justify the valuation.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillars sharp pullback and upcoming earnings report are driving debate, with traders questioning whether strong backlog and data-center power demand can justify elevated expectations or whether the selloff reflects concerns about slowing AI infrastructure spending. Some see the stock as oversold and are buying the dip, while others expect further weakness if guidance disappoints.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access U.S. cell sites, including Crown Castles towers, have driven the rally as traders weigh the prospect of a new source of leasing demand. No agreement is confirmed, and the community is divided over whether the potential business is realistic and how it could affect tower owners and wireless carriers.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charters steep selloff is drawing attention amid concerns about broadband subscriber losses, competition and its heavy debt burden. Bears see a deteriorating cable business, while bulls argue the valuation is too low given cash flow, Spectrum Mobile growth and the Cox deal; possible SpaceX ties remain speculation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Novartis/Aviditys Phase 3 failure in DM1 has prompted a sharp read-through debate around Sareptas SRP-1003 program: some traders see a weakened competitor, while others worry the result questions whether DMPK knockdown can translate into functional benefit. The community is looking to Sareptas own DM1 and FSHD data to clarify the risk, with optimism that its different delivery approach may produce stronger results offset by uncertainty about clinical impact.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention centers on Helus Pharmas expected Q4 2026 Phase 3 topline results for HLP003, its investigational add-on treatment for major depressive disorder. Traders are split between optimism that the readout could validate the program and concerns about trial uncertainty, potential dilution, and volatility around the binary catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alibaba Group Stock In Focus Following $1.3B Sale Of Intime Stores: Retail Sentiment Brightens

Equity

Alibaba, which has a 99% stake in Intime, had bought the company in 2017 for $2.6 billion in a bid to grow its physical stores segment

First Trust Exchange-Traded Fund III - First Trust Long/Short Equity ETF

Neutral Sentiment

Chinese retail giant Alibaba Group Holding’s ADR shares rose in after-hours trading session on Tuesday after the company said it was divesting its Intime Stores division for $1.3 billion, lifting retail sentiment.The retail giant will reportedly book a $1.3 billion loss from the divestment, according to several media reports. &nbsp;A consortium made up of Youngor Fashion and members of Intime's management team have bought the business for 7.4 billion yuan, Reuters reported.The latest transaction is part of Alibaba's strategy to combine its domestic and international e-commerce businesses, and divest certain non-core assets. The move follows a revamp last year that split the company into six business units. The company also saw a series of top management changes following the revamp.Alibaba, which has a 99% stake in Intime, had bought the company in 2017 for $2.6 billion in a bid to grow its physical stores segment. Its other consumer sector assets up for sale include Freshippo and RT-Mart, according to a a Reuters report.Retail sentiment on Stocktwits turned ‘bullish’ (57/100) from ‘bearish’ (28/100) a day ago.<figure class="image"><img style="aspect-ratio:1310/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_18_at_1_35_35_PM_ea06ae092f.png" alt="Screenshot 2024-12-18 at 1.35.35 PM.png" width="1310" height="314"><figcaption>BABA sentiment meter and message volumes on Dec 18 as of 3:06 am ET</figcaption></figure>Bullish sentiment among Stocktwits users centered around an expectation of an imminent price increase. Many retail investors are predicting a rally of Chinese stocks by the end of the year, according to an ongoing Stocktwits poll.One user was predicting a $100 price target on Alibaba, another pegged a $120 price by year-end.<stembedurl>https://stocktwits.com/TheProphetOfProfit/message/596923592</stembedurl><stembedurl>https://stocktwits.com/davidl2/message/596925407</stembedurl>Last week, Alibaba stock rose on the back of optimism from China stimulus but caution set in as trade data from Chinese government showed falling numbers for November.According to a recent Barron's report, Chinese exports in November increased by 6.7%, a decline compared to the 12.7% jump in October. That number didn’t take into account imminent tariffs that could impact a number of Chinese consumer stocks.For updates and corrections, email newsroom[at]stocktwits[dot]com.

NANJING, CHINA - NOVEMBER 13 2024: A view of the office towers of Alibaba Group and Ant Group in Nanjing in east China's Jiangsu province Wednesday, Nov. 13, 2024. (Photo credit should read FANG DONGXU / Feature China/Future Publishing via Getty Images)

Invesco Golden Dragon China ETF

SPDR NYSE Technology ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

FTLS News